BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 27396987)

  • 1. Viability of Lucilia sericata maggots after exposure to wound antiseptics.
    Daeschlein G; Napp M; Assadian O; von Podewils S; Reese K; Hinz P; Matiasek J; Spitzmueller R; Humphreys P; Jünger M; Kramer A
    Int Wound J; 2017 Jun; 14(3):512-515. PubMed ID: 27396987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of broad-spectrum antiseptics in production of disinfected maggots of Lucilia sericata for use in wound debridement therapy.
    Taleb M
    Wound Repair Regen; 2021 Nov; 29(6):1017-1023. PubMed ID: 34633134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biosurgical débridement using Lucilia sericata-maggots - an update].
    Nenoff P; Herrmann A; Gerlach C; Herrmann J; Simon JC
    Wien Med Wochenschr; 2010 Dec; 160(21-22):578-85. PubMed ID: 20714816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maggot debridement therapy and complementary wound care: a case series from Nigeria.
    Yusuf MA; Ibrahim BM; Oyebanji AA; Abubakar F; Ibrahim M; Ibrahim Jalo R; Aminu A; Akbarzadeh K; Azam M; Sheshe AA; Ganiyu OO; Abubakar MK; Salisu WJ; Kordshouli RS; Adamu AY; Takalmawa H; Daneji I; Aliyu M; Ibrahim MG; Kabuga AI; Abdullahi AS; Abbas MA
    J Wound Care; 2022 Nov; 31(11):996-1005. PubMed ID: 36367805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards next generation maggot debridement therapy: transgenic Lucilia sericata larvae that produce and secrete a human growth factor.
    Linger RJ; Belikoff EJ; Yan Y; Li F; Wantuch HA; Fitzsimons HL; Scott MJ
    BMC Biotechnol; 2016 Mar; 16():30. PubMed ID: 27006073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defensins of
    Bazaliński D; Przybek-Mita J; Lisowicz K; Skórka M; Więch P
    Int J Environ Res Public Health; 2023 Mar; 20(7):. PubMed ID: 37047972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of maggot debridement therapy in the treatment of chronic wounds in hospitalised and ambulatory patients.
    Gilead L; Mumcuoglu KY; Ingber A
    J Wound Care; 2012 Feb; 21(2):78, 80, 82-85. PubMed ID: 22584527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Maggots of Lucilia sericata in treatment of intractable wounds].
    Orkiszewski M
    Wiad Lek; 2007; 60(7-8):381-5. PubMed ID: 18175560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical applications for maggots in wound care.
    Mumcuoglu KY
    Am J Clin Dermatol; 2001; 2(4):219-27. PubMed ID: 11705249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maggot debridement therapy for an electrical burn injury with instructions for the use of Lucilia sericata larvae.
    Nasoori A; Hoomand R
    J Wound Care; 2017 Dec; 26(12):734-741. PubMed ID: 29244970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of the use of maggots in wound therapy.
    Gupta A
    Ann Plast Surg; 2008 Feb; 60(2):224-7. PubMed ID: 18216520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro antibacterial activity of Lucilia sericata maggot secretions.
    Daeschlein G; Mumcuoglu KY; Assadian O; Hoffmeister B; Kramer A
    Skin Pharmacol Physiol; 2007; 20(2):112-5. PubMed ID: 17167275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth and survival of blowfly Lucilia sericata larvae under simulated wound conditions: implications for maggot debridement therapy.
    Čičková H; Kozánek M; Takáč P
    Med Vet Entomol; 2015 Dec; 29(4):416-24. PubMed ID: 26382290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Maggot therapy in wound management].
    Falch BM; de Weerd L; Sundsfjord A
    Tidsskr Nor Laegeforen; 2009 Sep; 129(18):1864-7. PubMed ID: 19844278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Midgut lysozymes of Lucilia sericata - new antimicrobials involved in maggot debridement therapy.
    Valachova I; Takac P; Majtan J
    Insect Mol Biol; 2014 Dec; 23(6):779-87. PubMed ID: 25098233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the optimal treatment time for larval therapy? A study on incubation time and tissue debridement by bagged maggots of the greenbottle fly, Lucilia sericata.
    Wilson MR; Nigam Y; Knight J; Pritchard DI
    Int Wound J; 2019 Feb; 16(1):219-225. PubMed ID: 30379404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The biosurgical wound debridement: experimental investigation of efficiency and practicability.
    Blake FA; Abromeit N; Bubenheim M; Li L; Schmelzle R
    Wound Repair Regen; 2007; 15(5):756-61. PubMed ID: 17971022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of hydrogel dressings on maggot development.
    Thomas S; Andrews A
    J Wound Care; 1999 Feb; 8(2):75-7. PubMed ID: 10232202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biocompatibility of antimicrobials to maggot debridement therapy: medical maggots Lucilia sericata (Diptera: Calliphoridae) exhibit tolerance to clinical maximum doses of antimicrobials.
    Peck GW; Kirkup BC
    J Med Entomol; 2012 Sep; 49(5):1137-43. PubMed ID: 23025196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do maggots have an influence on bacterial growth? A study on the susceptibility of strains of six different bacterial species to maggots of Lucilia sericata and their excretions/secretions.
    Cazander G; van Veen KE; Bernards AT; Jukema GN
    J Tissue Viability; 2009 Aug; 18(3):80-7. PubMed ID: 19362001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.